Case Report
BibTex RIS Cite
Year 2024, Volume: 6 Issue: 1, 15 - 16, 30.04.2024
https://doi.org/10.51262/ejtox.1400570

Abstract

References

  • Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001 Oct 2;165(7):917- 28. PMID: 11599334; PMCID: PMC81503.
  • Steinkellner T, Freissmuth M, Sitte HH, Montgomery T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and D-amphetamine. Biol Chem. 2011 Jan;392(1-2):103-15. doi: 10.1515/BC.2011.016. PMID: 21194370; PMCID: PMC4497800.
  • Jansen KL, Theron L. Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): a consideration of the issues. J Psychoactive Drugs. 2006 Mar;38(1):1-12. doi: 10.1080/02791072.2006.10399822. PMID: 16681170.
  • King A, Dimovska M, Bisoski L. Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension. Curr Hypertens Rep. 2018 Feb 24;20(1):8. doi: 10.1007/s11906-018-0807-9. PMID: 29478133.
  • Chan TC, Evans SD, Clark RF. Drug-induced hyperthermia. Crit Care Clin. 1997 Oct;13(4):785-808. doi: 10.1016/s0749- 0704(05)70369-9. PMID: 9330841.
  • Brown H, Pollard KA. Drugs of Abuse: Sympathomimetics. Crit Care Clin. 2021 Jul;37(3):487-499. doi: 10.1016/j. ccc.2021.03.002. PMID: 34053702.
  • Shannon M. Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatr Emerg Care. 2000 Oct;16(5):377-80. doi: 10.1097/00006565-200010000-00022. PMID: 11063374.

One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome

Year 2024, Volume: 6 Issue: 1, 15 - 16, 30.04.2024
https://doi.org/10.51262/ejtox.1400570

Abstract

Sympathomimetic syndromes are rare medical conditions involving complex clinical pictures caused by substances that have a stimulatory effect on the sympathetic nervous system or have similar effects to the sympathetic nervous system. In this case report, the clinical manifestations of sympathomimetic syndromes, the diagnostic process, treatment strategies and the difficulties encountered especially in emergency medicine will be reviewed.

References

  • Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001 Oct 2;165(7):917- 28. PMID: 11599334; PMCID: PMC81503.
  • Steinkellner T, Freissmuth M, Sitte HH, Montgomery T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and D-amphetamine. Biol Chem. 2011 Jan;392(1-2):103-15. doi: 10.1515/BC.2011.016. PMID: 21194370; PMCID: PMC4497800.
  • Jansen KL, Theron L. Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): a consideration of the issues. J Psychoactive Drugs. 2006 Mar;38(1):1-12. doi: 10.1080/02791072.2006.10399822. PMID: 16681170.
  • King A, Dimovska M, Bisoski L. Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension. Curr Hypertens Rep. 2018 Feb 24;20(1):8. doi: 10.1007/s11906-018-0807-9. PMID: 29478133.
  • Chan TC, Evans SD, Clark RF. Drug-induced hyperthermia. Crit Care Clin. 1997 Oct;13(4):785-808. doi: 10.1016/s0749- 0704(05)70369-9. PMID: 9330841.
  • Brown H, Pollard KA. Drugs of Abuse: Sympathomimetics. Crit Care Clin. 2021 Jul;37(3):487-499. doi: 10.1016/j. ccc.2021.03.002. PMID: 34053702.
  • Shannon M. Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatr Emerg Care. 2000 Oct;16(5):377-80. doi: 10.1097/00006565-200010000-00022. PMID: 11063374.
There are 7 citations in total.

Details

Primary Language English
Subjects Emergency Medicine
Journal Section Case Reports
Authors

Mustafa Tolga Özdal 0009-0004-4878-7129

Melih Yüksel 0000-0002-0793-3693

Mehmet Oğuzhan Ay 0000-0003-1061-5327

Yeşim İşler 0000-0002-6389-5361

Umut Ocak 0000-0002-6549-4246

Zülfi Engindeniz 0000-0003-1874-5097

Halil Kaya 0000-0003-2005-6100

Publication Date April 30, 2024
Submission Date December 5, 2023
Acceptance Date April 1, 2024
Published in Issue Year 2024 Volume: 6 Issue: 1

Cite

APA Özdal, M. T., Yüksel, M., Ay, M. O., İşler, Y., et al. (2024). One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome. Eurasian Journal of Toxicology, 6(1), 15-16. https://doi.org/10.51262/ejtox.1400570
AMA Özdal MT, Yüksel M, Ay MO, İşler Y, Ocak U, Engindeniz Z, Kaya H. One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome. Eurasian J Tox. April 2024;6(1):15-16. doi:10.51262/ejtox.1400570
Chicago Özdal, Mustafa Tolga, Melih Yüksel, Mehmet Oğuzhan Ay, Yeşim İşler, Umut Ocak, Zülfi Engindeniz, and Halil Kaya. “One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome”. Eurasian Journal of Toxicology 6, no. 1 (April 2024): 15-16. https://doi.org/10.51262/ejtox.1400570.
EndNote Özdal MT, Yüksel M, Ay MO, İşler Y, Ocak U, Engindeniz Z, Kaya H (April 1, 2024) One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome. Eurasian Journal of Toxicology 6 1 15–16.
IEEE M. T. Özdal, M. Yüksel, M. O. Ay, Y. İşler, U. Ocak, Z. Engindeniz, and H. Kaya, “One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome”, Eurasian J Tox, vol. 6, no. 1, pp. 15–16, 2024, doi: 10.51262/ejtox.1400570.
ISNAD Özdal, Mustafa Tolga et al. “One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome”. Eurasian Journal of Toxicology 6/1 (April 2024), 15-16. https://doi.org/10.51262/ejtox.1400570.
JAMA Özdal MT, Yüksel M, Ay MO, İşler Y, Ocak U, Engindeniz Z, Kaya H. One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome. Eurasian J Tox. 2024;6:15–16.
MLA Özdal, Mustafa Tolga et al. “One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome”. Eurasian Journal of Toxicology, vol. 6, no. 1, 2024, pp. 15-16, doi:10.51262/ejtox.1400570.
Vancouver Özdal MT, Yüksel M, Ay MO, İşler Y, Ocak U, Engindeniz Z, Kaya H. One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome. Eurasian J Tox. 2024;6(1):15-6.

Dizinler ve Platformlar

14707   14765   15059  20298 23132